Search results
Showing 451 to 500 of 8903 results
NICE's partners
NICE's past research and projects
Home News Podcasts NICE's prioritisation board: focus on what matters most Podcasts 27 June 2025 Listen About this episode In this episode
Four AI technologies conditionally recommended to help detect undiagnosed fragility fractures
The technologies could help healthcare professionals spot hidden spinal fractures in patients undergoing routine CT scans.
NICE responds to publication of the government's Life Sciences Sector Plan
We welcome the publication of the government's Life Sciences Sector Plan, which sets out how NICE will ensure patients get faster, fairer access to transformative new medicines and life-changing healthtech, while supporting a thriving life sciences industry in the UK.
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios for principle social workers Principle social workers -...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios for principle social workers Principle social workers -...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios for principle social workers Principle social workers -...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios for principle social workers Principle social workers -...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios for principle social workers Principle social workers -...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios for principle social workers Principle social workers -...
Our science policy and research programme team produces high-quality, impactful research.
Before 2022, we used different processes for assessing technologies. You can view the previous process and methods guides below.
A step-by-step summary about how we develop our technology appraisal guidance.
NICE priority methodological research areas.
Home Implementing NICE guidance Social care...
Our role in the Innovative Licensing and Access Pathway (ILAP)
The Innovative Licensing and Access Pathway (ILAP) is a unique initiative which works with medicine developers early on to help get new medicines to patients faster.
Access free webinars and paid-for masterclasses.
Resources to help with NHS access, system engagement and understanding the therapeutic landscape.
We assess the value of digital health technologies that offer the greatest potential to improve health and wellbeing.
Home Get involved...
Home Get involved...
GPs help to bring a primary care perspective to the guidance that we produce.
GPs help to bring a primary care perspective to the guidance that we produce.
NICE guidelines are evidence-based recommendations for health and care in England and Wales.
Help us improve NICE: take part in research to help us develop better products and services.
Help us improve NICE: take part in research to help us develop better products and services.
Mirikizumab for previously treated moderately to severely active Crohn's disease (TA1080)
Evidence-based recommendations on mirikizumab (Omvoh) for previously treated moderately to severely active Crohn's disease in adults.
Zanubrutinib for treating relapsed or refractory mantle cell lymphoma (TA1081)
Evidence-based recommendations on zanubrutinib for treating relapsed or refractory mantle cell lymphoma in adults who have had 1 line of treatment only.
One-piece closed bags for colostomies: late-stage assessment (HTG754)
Late stage assessment (LSA) guidance on one-piece closed bags for colostomies
View recommendations for HTG754Show all sections
Evidence-based recommendations on pulsed-field ablation for atrial fibrillation. This involves using electric field energy to destroy heart cells that are transmitting abnormal electrical impulses.
Home Get involved Help develop quality standards...
Home Get involved Help develop quality standards...
Home Get involved Help develop quality standards...
Home Get involved Help develop quality standards...
Our experts can offer advice and support in contextualising our guidelines, or helping you adapt our content to your country or local context.
Home Get involved Help develop quality standards...
Home Get involved Help develop quality standards...
We provide an advisory service for international health organisations, ministries and government agencies whose task is to improve evidence-based decision making in health and social care.
NICE guidance and standards support health professionals by providing evidence-based recommendations that enhance clinical decision-making and patient care.
Late-stage assessment (LSA) guidance on intermittent urethral catheters for chronic incomplete bladder emptying in adults.
Join NICE's people and communities network
Join NICE's people and communities network
Making a positive impact: people and communities network case studies
Making a positive impact: NICE people and communities network case studies
Making a positive impact: people and communities network case studies
Making a positive impact: NICE people and communities network case studies
We want you to help NICE to develop our guidance for NHS and care services.
We want you to help NICE to develop our guidance for NHS and care services.
Read NICE's patient and public involvement policy.
Read NICE's patient and public involvement policy.
Involving you in the development of NICE guidance.